Diabetes News and Research

Latest Diabetes News and Research

Biolife granted U.S. patent for novel effervescent oral peptide delivery technology

BioLife today announced that the United States Patent and Trademark Office has granted U.S. Patent 12,667,605 B2 for its novel effervescent oral peptide delivery technology, designed to support current and future peptide therapeutics for obesity, diabetes and metabolic disease.

10 Sep 2026

Symptomless liver condition linked to heart and kidney disease

A common liver condition thought to be harmless could be dramatically increasing the risk of heart disease, kidney failure and premature death, according to a new review led by University of Manchester and Northern Care Alliance NHS Foundation Trust researchers.

10 Sep 2026

Gut microbiome may reveal inflammation and future disease risk better than age

Gut microbiota composition explained more variation than chronological age in nearly all inflammatory cytokines and most physiological measures examined, with specific microbial profiles linked to markedly different patterns of inflammation across adulthood. People with the Bacteroides 2 enterotype showed an inflammaging-like profile decades earlier than other groups and had a higher risk of subsequent disease, while a high-diversity microbiota profile was associated with lower inflammation and reduced disease incidence.

9 Sep 2026

The link between PM2.5 and ADHD held up after researchers tested other explanations

Using two decades of U.S. county-level data, researchers found that long-term PM2.5 exposure was robustly associated with higher childhood ADHD prevalence, while associations with low birth weight and diabetes weakened after accounting for county-specific temporal trends. The ADHD association persisted after socioeconomic, demographic, state-level, exposure-period, and spatial adjustments, although the ecological study cannot establish an individual-level causal relationship.

9 Sep 2026

The link between fish and pregnancy hypertension may start before conception

In a nationwide Japanese cohort of more than 86,000 women, higher fish intake before pregnancy was associated with lower odds of early-onset hypertensive disorders of pregnancy, while fish intake during pregnancy showed different associations with late-onset disease, particularly among women who had not previously given birth. Total dietary omega-3 and omega-6 PUFA intake showed much less consistent associations, suggesting that the relationship with fish consumption may not be explained by total PUFA intake alone.

9 Sep 2026

Digital companion apps help secure long-term habits during GLP-1 therapy

Glucagon-like peptide-1 (GLP-1) medications have revolutionized weight management, yet high dropout rates and rapid weight regain remain significant hurdles for many patients.

9 Sep 2026

New AI model forecasts glucose changes in type 1 diabetes patients

Diabetes is one of the most common chronic diseases, affecting around 66 million adults in Europe - a figure projected to rise to more than 72 million by 2050.

9 Sep 2026

Johns Hopkins researchers identify human resistin as a key driver of inflammation

Researchers at Johns Hopkins Medicine have uncovered a critical biological mechanism that helps explain how inflammation is triggered and sustained in a wide range of diseases-highlighting a promising avenue for future therapeutic development.

9 Sep 2026

Why a shorter eating window may not mean better metabolic health

In a nationally representative cross-sectional study of 16,973 Korean adults, researchers identified three distinct eating patterns based on the timing and distribution of daily energy intake. Eating later within a shorter daily window was associated with higher odds of metabolic syndrome, elevated blood pressure, triglycerides, and fasting glucose, while frequent grazing showed a mixed metabolic profile.

8 Sep 2026

Cognitive behavioral therapy for insomnia may slow biological aging in older adults

A new UCLA Health study found that treatment of insomnia using cognitive behavioral therapy slowed the pace of biological aging in older adults.

8 Sep 2026

Stevia tastes sweet, but does your body react as if sugar is coming?

In a randomized, double-blind crossover study, researchers tested stevia alone and with glucose in adults with normal weight, overweight, or type 2 diabetes to assess acute effects on blood glucose, insulin, gut hormones, appetite, and subsequent food intake. Stevia produced no significant changes in the measured glycemic or hormonal responses compared with water and did not significantly modify responses to glucose, while appetite and subsequent energy intake were also generally unchanged.

8 Sep 2026

COVID-19 linked to lower subsequent risk of type 1 diabetes

New research to be presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2) shows that people who have had COVID-19 have a lower, rather than higher, risk of subsequent development of type 1 diabetes (T1D).

8 Sep 2026

Rice, seafood and water may help explain striking differences in metal exposure across US communities

Researchers compared urinary trace-metal profiles across 666 adults from six ethnic groups in three US cohorts, with up to 19 elements measured and paired serum measurements available for the Asian Indian MASALA cohort. Distinct metal patterns emerged across populations, with the findings suggesting that diet, drinking-water sources, regional hydrogeology, urban-rural conditions, smoking, and physiological handling may all contribute to differences in exposure profiles.

8 Sep 2026

Working shifts may change more than your sleep schedule

A cross-sectional analysis of 1,814 Japanese workers found that shift work was associated with lower raw seafood intake and shorter sleep patterns in both sexes, while female shift workers also consumed less milk and dairy products. Total energy intake was similar between work groups, but male shift workers were more likely to consider preference and convenience when choosing foods, highlighting potentially important differences in dietary quality and lifestyle rather than calorie intake.

8 Sep 2026

Could one amino acid help explain why men tend to live shorter lives?

A UK Biobank cohort and Mendelian randomization study involving 272,475 participants linked higher circulating tyrosine with greater all-cause mortality and genetically predicted higher tyrosine with shorter lifespan. After accounting for phenylalanine, the relationship with shorter lifespan was clearest in men, while findings in women were less consistent, suggesting a potential sex-specific role for tyrosine in longevity.

7 Sep 2026

GLP-1 treatment linked to 40% fewer asthma attacks

The diabetes and weight loss injection semaglutide can reduce asthma attacks by up to 40 per cent according to research presented at the European Respiratory Society (ERS) Congress in Barcelona, Spain.

7 Sep 2026

GLP-1 drugs looked promising for depression. The evidence tells a more complicated story

A systematic review of 43 studies found highly heterogeneous results for GLP-1 receptor agonists across animal models and human research assessing depression-, anxiety-, and stress-related outcomes. No study directly tested these drugs as a treatment for PTSD, and the available evidence does not currently support their use for depression or PTSD, although people with metabolic dysfunction may warrant further investigation.

7 Sep 2026

What mothers eat in pregnancy may shape a child’s weight years later

A prospective study of 252 mother-child pairs found that higher combined maternal fruit and vegetable intake during pregnancy was associated with lower odds of overweight or obesity in children at age four. Total and natural fruit juice showed no association, whereas higher commercial fruit juice intake was associated with increased odds, though the authors emphasized that this finding was exploratory.

7 Sep 2026

Atherosclerosis qualifies as an autoimmune disease

A new study in mice and patients shows that atherosclerosis meets the criteria for an autoimmune disease.

7 Sep 2026

GLP-1 drugs appear psychiatrically safe, but one finding still raises questions

A systematic review of 11 observational studies representing more than 4.9 million patients found that GLP-1 receptor agonists were generally associated with neutral or potentially protective psychiatric outcomes, although one obesity-focused cohort reported increased risks of depression, anxiety, and suicidal behavior. Direct evidence for antidepressant effects remains limited, with only one cross-sectional study using validated mood scales and no randomized trials in the final synthesis, meaning causality cannot be established

6 Sep 2026